GSK’s Nucala unlikely to get COPD use after panel vote
FDA due to make decision in September
FDA due to make decision in September
Fasenra can only be used after GSK rival, NICE says in draft decision
GSK also hopes to get IL-5 drug approved in COPD
Lacklustre performance from GSK as results season begins
GSK is aiming to revive its respiratory drugs franchise
But NICE rejects Dupixent in eczema